A Novel Mouse Model of Diffuse Intrinsic Pontine Glioma Initiated in Pax3-Expressing Cells

Neoplasia (United States)

Volumn 18, Issue 1, 2016, Pages 60-70

  Misuraca, Katherine L ^a   Hu, Guo ^a,b   Barton, Kelly L ^a,b   Chung, Alexander ^a,b   Becher, Oren J ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; KI 67 ANTIGEN; NESTIN; NEURON SPECIFIC NUCLEAR PROTEIN; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; PLATELET DERIVED GROWTH FACTOR B; PROTEIN P53; TRANSCRIPTION FACTOR PAX3; TRANSCRIPTION FACTOR SOX2; HISTONE; PAIRED BOX TRANSCRIPTION FACTOR; PAX3 PROTEIN, MOUSE; PLATELET DERIVED GROWTH FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN STEM; CANCER GRADING; CANCER MODEL; CONTROLLED STUDY; GENE MUTATION; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MEDULLA OBLONGATA; MESENCEPHALON; MOUSE; NEURAL STEM CELL; NEWBORN; NONHUMAN; PONTINE GLIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BRAIN STEM TUMOR; CELL TRANSFORMATION; DISEASE MODEL; ECTOPIC EXPRESSION; GENE EXPRESSION; GENETICS; GLIOMA; HUMAN; METABOLISM; MORTALITY; PATHOLOGY; TRANSGENIC MOUSE;

ANIMALS; BRAIN STEM NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; ECTOPIC GENE EXPRESSION; GENE EXPRESSION; GLIOMA; HISTONES; HUMANS; MICE; MICE, TRANSGENIC; NEOPLASM GRADING; PAIRED BOX TRANSCRIPTION FACTORS; PAX3 TRANSCRIPTION FACTOR; PLATELET-DERIVED GROWTH FACTOR;

EID: 84963976310     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1016/j.neo.2015.12.002     Document Type: Article

References (39)

1. Donaldson SS, Laningham F, Fisher PG Advances toward an understanding of brainstem gliomas. J Clin Oncol 2006, 24:1266-1272.
2. Hargrave D, Bartels U, Bouffet E Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol 2006, 7:241-248.
3. Khuong-Quang DA, Buczkowicz P, Rakopoulos P, Liu XY, Fontebasso AM, Bouffet E, Bartels U, Albrecht S, Schwartzentruber J, Letourneau L, et al. K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol 2012, 124:439-447.
4. Schwartzentruber J, Korshunov A, Liu XY, Jones DT, Pfaff E, Jacob K, Sturm D, Fontebasso AM, Quang DA, Tonjes M, et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 2012, 482:226-231.
5. Sturm D, Witt H, Hovestadt V, Khuong-Quang D-A, Jones David TW, Konermann C, Pfaff E, Tönjes M, Sill M, Bender S, et al. Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 2012, 22:425-437.
6. Wu G, Broniscer A, McEachron TA, Lu C, Paugh BS, Becksfort J, Qu C, Ding L, Huether R, Parker M, et al. Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet 2012, 44:251-253.
7. Castel D, Philippe C, Calmon R, Le Dret L, Truffaux N, Boddaert N, Pages M, Taylor KR, Saulnier P, Lacroix L, et al. Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes. Acta Neuropathol 2015, 130(6):815-827.
8. Paugh BS, Broniscer A, Qu C, Miller CP, Zhang J, Tatevossian RG, Olson JM, Geyer JR, Chi SN, da Silva NS, et al. Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma. J Clin Oncol 2011, 29:3999-4006.
9. Paugh BS, Qu C, Jones C, Liu Z, Adamowicz-Brice M, Zhang J, Bax DA, Coyle B, Barrow J, Hargrave D, et al. Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease. J Clin Oncol 2010, 28:3061-3068.
10. Barrow J, Adamowicz-Brice M, Cartmill M, MacArthur D, Lowe J, Robson K, Brundler MA, Walker DA, Coyle B, Grundy R Homozygous loss of ADAM3A revealed by genome-wide analysis of pediatric high-grade glioma and diffuse intrinsic pontine gliomas. Neuro Oncol 2011, 13:212-222.
11. Paugh BS, Zhu X, Qu C, Endersby R, Diaz AK, Zhang J, Bax DA, Carvalho D, Reis RM, Onar-Thomas A, et al. Novel oncogenic PDGFRA mutations in pediatric high-grade gliomas. Cancer Res 2013, 73:6219-6229.
12. Puget S, Philippe C, Bax DA, Job B, Varlet P, Junier M-P, Andreiuolo F, Carvalho D, Reis R, Guerrini-Rousseau L, et al. Mesenchymal transition and PDGFRA amplification/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomas. PLoS One 2012, 7.
13. Zarghooni M, Bartels U, Lee E, Buczkowicz P, Morrison A, Huang A, Bouffet E, Hawkins C Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights platelet-derived growth factor receptor and poly (ADP-ribose) polymerase as potential therapeutic targets. J Clin Oncol 2010, 28:1337-1344.
14. Buczkowicz P, Hoeman C, Rakopoulos P, Pajovic S, Letourneau L, Dzamba M, Morrison A, Lewis P, Bouffet E, Bartels U, et al. Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations. Nat Genet 2014, 46:451-456.
15. Fontebasso AM, Papillon-Cavanagh S, Schwartzentruber J, Nikbakht H, Gerges N, Fiset PO, Bechet D, Faury D, De Jay N, Ramkissoon LA, et al. Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma. Nat Genet 2014, 46:462-466.
16. Taylor KR, Mackay A, Truffaux N, Butterfield YS, Morozova O, Philippe C, Castel D, Grasso CS, Vinci M, Carvalho D, et al. Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma. Nat Genet 2014, 46:457-461.
17. Wu G, Diaz AK, Paugh BS, Rankin SL, Ju B, Li Y, Zhu X, Qu C, Chen X, Zhang J, et al. The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma. Nat Genet 2014, 46:444-450.
18. Monje M, Mitra SS, Freret ME, Raveh TB, Kim J, Masek M, Attema JL, Li G, Haddix T, Edwards MSB, et al. Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma. Proc Natl Acad Sci 2011, 108:4453-4458.
19. Fischbein NJ, Prados MD, Wara W, Russo C, Edwards MS, Barkovich AJ Radiologic classification of brain stem tumors: correlation of magnetic resonance imaging appearance with clinical outcome. Pediatr Neurosurg 1996, 24:9-23.
20. Tate MC, Lindquist RA, Nguyen T, Sanai N, Barkovich AJ, Huang EJ, Rowitch DH, Alvarez-Buylla A Postnatal growth of the human pons: a morphometric and immunohistochemical analysis. J Comp Neurol 2015, 523:449-462.
21. Barton KL, Misuraca K, Cordero F, Dobrikova E, Min HD, Gromeier M, Kirsch DG, Becher OJ PD-0332991, a CDK4/6 inhibitor, significantly prolongs survival in a genetically engineered mouse model of brainstem glioma. PLoS One 2013, 8.
22. Becher OJ, Hambardzumyan D, Walker TR, Helmy K, Nazarian J, Albrecht S, Hiner RL, Gall S, Huse JT, Jabado N, et al. Preclinical evaluation of radiation and perifosine in a genetically and histologically accurate model of brainstem glioma. Cancer Res 2010, 70:2548-2557.
23. Lewis PW, Muller MM, Koletsky MS, Cordero F, Lin S, Banaszynski LA, Garcia BA, Muir TW, Becher OJ, Allis CD Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma. Science 2013, 340:857-861.
24. Misuraca KL, Barton KL, Chung A, Diaz AK, Conway SJ, Corcoran DL, Baker SJ, Becher OJ Pax3 expression enhances PDGF-B-induced brainstem gliomagenesis and characterizes a subset of brainstem glioma. Acta Neuropathol Commun 2014, 2.
25. Hou L, Loftus SK, Incao A, Chen A, Pavan WJ Complementation of melanocyte development in SOX10 mutant neural crest using lineage-directed gene transfer. Dev Dyn 2004, 229:54-62.
26. Becher OJ, Holland EC Evidence for and against regional differences in neural stem and progenitor cells of the CNS. Genes Dev 2010, 24:2233-2238.
27. Encinas JM, Vaahtokari A, Enikolopov G Fluoxetine targets early progenitor cells in the adult brain. Proc Natl Acad Sci U S A 2006, 103:8233-8238.
28. Hoffman RM Patient-derived orthotopic xenografts: better mimic of metastasis than subcutaneous xenografts. Nat Rev Cancer 2015, 15:451-452.
29. Misuraca KL, Cordero FJ, Becher OJ Pre-clinical models of diffuse intrinsic pontine glioma. Front Oncol 2015, 5:172.
30. Bang AG, Papalopulu N, Goulding MD, Kintner C Expression of Pax-3 in the lateral neural plate is dependent on a Wnt-mediated signal from posterior nonaxial mesoderm. Dev Biol 1999, 212:366-380.
31. Bang AG, Papalopulu N, Kintner C, Goulding MD Expression of Pax-3 is initiated in the early neural plate by posteriorizing signals produced by the organizer and by posterior non-axial mesoderm. Development 1997, 124:2075-2085.
32. Pani L, Horal M, Loeken MR Rescue of neural tube defects in Pax-3-deficient embryos by p53 loss of function: implications for Pax-3-dependent development and tumorigenesis. Genes Dev 2002, 16:676-680.
33. Tanabe Y, Jessell TM Diversity and pattern in the developing spinal cord. Science 1996, 274:1115-1123.
34. (2013). Allen Institute for Brain Science. Allen Developing Mouse Brain Atlas. Editor (ed)^(eds): City.
35. Ballester LY, Wang Z, Shandilya S, Miettinen M, Burger PC, Eberhart CG, Rodriguez FJ, Raabe E, Nazarian J, Warren K, et al. Morphologic characteristics and immunohistochemical profile of diffuse intrinsic pontine gliomas. Am J Surg Pathol 2013, 37:1357-1364.
36. Chan KM, Fang D, Gan H, Hashizume R, Yu C, Schroeder M, Gupta N, Mueller S, James CD, Jenkins R, et al. The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression. Genes Dev 2013, 27:985-990.
37. Funato K, Major T, Lewis PW, Allis CD, Tabar V Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation. Science 2014, 346:1529-1533.
38. Subashi E, Cordero FJ, Halvorson KG, Qi Y, Nouls JC, Becher OJ, Allan Johnson G Tumor location, but not H3.3K27M, significantly influences the blood-brain-barrier permeability in a genetic mouse model of pediatric high-grade glioma. J Neurooncol 2015, [Epub ahead of print].
39. Sharma MK, Mansur DB, Reifenberger G, Perry A, Leonard JR, Aldape KD, Albin MG, Emnett RJ, Loeser S, Watson MA, et al. Distinct genetic signatures among pilocytic astrocytomas relate to their brain region origin. Cancer Res 2007, 67:890-900.